arrow
Back
M

Michael Charlton

madrigal pharmaceuticals

92H-index
405Paper Count
4.2WCitation Count
Published Papers 206
Publication Date
Response to “Aspirin for Primary Prevention in Metabolic Dysfunction-Associated Steatotic Liver Disease”
err2026-01-22
err0
PREAI
errTsubasa Tsutsumi; Michael R. Charlton; Takumi Kawaguchi; Mary E. Rinella
errShare
errSave
Assessing predictive performance of FIB-4 in settings with lower prevalence of liver fibrosis
err2025-12-23
err0
PREAI
errMary E. Rinella; Michael R. Charlton; Yestle Kim; Suneil Hosmane; Tom O’Connell
errShare
errSave
Aspirin Use and Mediterranean Diet Adherence as Factors Associated With Overall Mortality in Patients With MASLD in NHANES
err2025-11-01
err0
PREAI
errTsutsumi, Tsubasa; Charlton, Michael R.; Oddo, Vanessa M.; Vilt, Sarah; Kim, Hee Yeon; Micic, Dejan; Odenwald, Matthew A.; Kawaguchi, Takumi; Mcdonald, Edwin K.; Rinella, Mary E.
errShare
errSave
Efficacy and safety of ervogastat alone and in combination with clesacostat in patients with biopsy-confirmed metabolic dysfunction-associated steatohepatitis and F2–F3 fibrosis (MIRNA): results from a phase 2, randomised, double-blind, double-dummy study
err2025-07-31
err0
PREAI
errVincent Wai-Sun Wong; Neeta B Amin; Hirokazu Takahashi; Amanda Darekar; Frank Tacke; Jan Kiszko; Hector Rodriguez; Atsushi Nakajima; Naim Alkhouri; Michael Charlton; Quentin M Anstee
errShare
errSave
errShare
errSave
Expert Panel Recommendations: Practical Clinical Applications for Initiating and Monitoring Resmetirom in Patients With MASH/NASH and Moderate to Noncirrhotic Advanced Fibrosis
err2024-12-01
err7
errOAAI
errNoureddin, Mazen; Charlton, Michael R.; Harrison, Stephen A.; Bansal, Meena B.; Alkhouri, Naim; Loomba, Rohit; Sanyal, Arun J.; Rinella, Mary E.
errShare
errSave
errShare
errSave
Colonel Stephen A. Harrison, MD - The passing of a Titan
err2024-09-01
err0
errOAAI
errCharlton, Michael; Loomba, Rohit; Ratziu, Vlad; Rinella, Mary
errShare
errSave
Characterizing Clinical and Economic Outcomes among Patients with MASH and Type 2 Diabetes Mellitus Treated with Glucagon-Like Peptide 1 (GLP1)-A Cohort Study
err2024-06-14
err0
PREAI
errKim, Yestle; Qian, Christina; Fishman, Jesse; Szabo, Shelagh M.; Rochon, Hannah; Sun, Rosie; Medicis, Joe; Charlton, Michael
errShare
errSave
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
err2024-02-08
err342
errOAAI
errHarrison, Stephen A.; Bedossa, Pierre; Guy, Cynthia D.; Schattenberg, Joern M.; Loomba, Rohit; Taub, Rebecca; Labriola, Dominic; Moussa, Sam E.; Neff, Guy W.; Rinella, Mary E.; Anstee, Quentin M.; Abdelmalek, Manal F.; Younossi, Zobair; Baum, Seth J.; Francque, Sven; Charlton, Michael R.; Newsome, Philip N.; Lanthier, Nicolas; Schiefke, Ingolf; Mangia, Alessandra; Pericas, Juan M.; Patil, Rashmee; Sanyal, Arun J.; Noureddin, Mazen; Bansal, Meena B.; Alkhouri, Naim; Castera, Laurent; Rudraraju, Madhavi; Ratziu, Vlad
errShare
errSave
Macrophage RAGE activation is proinflammatory in NASH
err2024-01-04
err5
errOAAI
errParthasarathy, Gopanandan; Mauer, Amy S.; Golla, Naresh; Daniel, P. Vineeth; Kim, Lily H.; Sidhu, Guneet S.; Marek III, George W.; Loeuillard, Emilien; Krishnan, Anuradha; Lee, Hyun Se Kim; Pavelko, Kevin D.; Charlton, Michael; Hirsova, Petra; Ilyas, Sumera I.; Malhi, Harmeet
errShare
errSave
Endocrine aspects of metabolic dysfunction-associated steatotic liver disease (MASLD): Beyond insulin resistance
err2023-12-01
err41
errOAAI
errHutchison, Alan L.; Tavaglione, Federica; Romeo, Stefano; Charlton, Michael
errShare
errSave
Efficacy and Safety of Sofosbuvir/Velpatasvir Plus Ribavirin in Patients with Hepatitis C Virus-Related Decompensated Cirrhosis
err2023-09-29
err7
errOAAI
errFlamm, Steven; Lawitz, Eric; Borg, Brian; Charlton, Michael; Landis, Charles; Reddy, K. Rajender; Shiffman, Mitchell; Alsina, Angel; Chang, Charissa; Ravendhran, Natarajan; Hernandez, Candido; Hezode, Christophe; Scherbakovsky, Stacey; Mercier, Renee-Claude; Samuel, Didier
errShare
errSave
Liver Transplantation 2023: Status Report, Current and Future Challenges
err2023-07-01
err71
errOAAI
errTerrault, Norah A.; Francoz, Claire; Berenguer, Marina; Charlton, Michael; Heimbach, Julie
errShare
errSave
The Omicron Sub-Variant BA.4 Displays a Remarkable Lack of Clinical Signs in a Golden Syrian Hamster Model of SARS-CoV-2 Infection
err2023-05-10
err2
errOAAI
errDavies, Elizabeth R.; Ryan, Kathryn A.; Bewley, Kevin R.; Coombes, Naomi S.; Salguero, Francisco J.; Carnell, Oliver T.; Biddlecombe, Sarah; Charlton, Michael; Challis, Amy; Cross, Eleanor S.; Handley, Alastair; Ngabo, Didier; Weldon, Thomas M.; Hall, Yper; Funnell, Simon G. P.
errShare
errSave
SARS-CoV-2 Disease Severity in the Golden Syrian Hamster Model of Infection Is Related to the Volume of Intranasal Inoculum
err2023-03-14
err8
errOAAI
errHandley, Alastair; Ryan, Kathryn A.; Davies, Elizabeth R.; Bewley, Kevin R.; Carnell, Oliver T.; Challis, Amy; Coombes, Naomi S.; Fotheringham, Susan A.; Gooch, Karen E.; Charlton, Michael; Harris, Debbie J.; Kennard, Chelsea; Ngabo, Didier; Weldon, Thomas M.; Salguero, Francisco J.; Funnell, Simon G. P.; Hall, Yper
errShare
errSave
Preservation solutions for static cold storage in donation after circulatory death and donation after brain death liver transplantation in the United States
err2022-09-01
err8
errOAAI
errCotter, Thomas G.; Odenwald, Matthew A.; Perez-Gutierrez, Angelica; Jayant, Kumar; DiSabato, Diego; Charlton, Michael; Fung, John
errShare
errSave